Synthonics Inc

Synthonics, Inc. is a privately held company based in Blacksburg, Virginia. With 11 employees, the company generates approximately $5.3 million in annual revenue. Synthonics specializes in the discovery and development of patentable drugs utilizing its proprietary metal coordination chemistry. This unique approach involves binding metals to existing pharmaceutical agents, resulting in enhanced absorption and potentially greater therapeutic benefits compared to traditional medications. The company's current focus is on developing improved versions of drugs like T3 (liothyronine) and levodopa, which suffer from short half-lives, limiting their effectiveness. Synthonics believes its metal coordination chemistry can address this challenge and improve patient outcomes. For more information about Synthonics Inc. and its innovative drug development solutions, please visit their website at synthonicsinc.com.